Odyssey Health (ODYY) Cash from Operations (QoQ) (2015 - 2026)
Odyssey Health (ODYY) Cash from Operations (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.07 Mn | 771,705.04 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -12.05% |
| Jan 31, 2026 | -0.09% |
| Oct 31, 2025 | -489.22% |
| Jul 31, 2025 | -1,104.67% |
| Apr 30, 2025 | 91.43% |
| Jan 31, 2025 | 81.22% |
| Oct 31, 2024 | -290.53% |
| Jul 31, 2024 | 65.44% |
| Apr 30, 2024 | 79.71% |
| Jan 31, 2024 | -1,414.91% |
| Oct 31, 2023 | 50.01% |
| Jul 31, 2023 | 27.91% |
| Apr 30, 2023 | 81.61% |
| Jan 31, 2023 | -217.48% |
| Oct 31, 2022 | -126.36% |
| Jul 31, 2022 | 211.35% |
| Apr 30, 2022 | -131.19% |
| Jan 31, 2022 | 63.99% |
| Oct 31, 2021 | -63.07% |
| Jul 31, 2021 | 61.31% |